Terms: = Liver cancer AND NCOA4, RP11-481A12_4, 8031, ENSG00000138293, PTC3, ELE1, Q13772, RFG, DKFZp762E1112, ARA70
57218 results:
1. Use of Natural Language Processing to Infer Sites of Metastatic Disease From Radiology Reports at Scale.
Tay SB; Low GH; Wong GJE; Tey HJ; Leong FL; Li C; Chua MLK; Tan DSW; Thng CH; Tan IBH; Tan RSYC
JCO Clin Cancer Inform; 2024 May; 8():e2300122. PubMed ID: 38788166
[TBL] [Abstract] [Full Text] [Related]
2. Induction of Hepatoma Cell Pyroptosis by Endogenous Lipid Geranylgeranoic Acid-A Comparison with Palmitic Acid and Retinoic Acid.
Shidoji Y
Cells; 2024 May; 13(10):. PubMed ID: 38786033
[TBL] [Abstract] [Full Text] [Related]
3. Outcomes of Y90 Radioembolization for Hepatocellular Carcinoma in Patients Previously Treated with Transarterial Embolization.
Zhao K; Son S; Karimi A; Marinelli B; Erinjeri JP; Alexander ES; Sotirchos VS; Harding JJ; Soares KC; Ziv E; Covey A; Sofocleous CT; Yarmohammadi H
Curr Oncol; 2024 May; 31(5):2650-2661. PubMed ID: 38785481
[TBL] [Abstract] [Full Text] [Related]
4. Bacterial metabolism-triggered-chemiluminescence-based point-of-care testing platform for sensitive detection and photothermal inactivation of Staphylococcus aureus.
Yu X; Ma Y; Liu S; Qi C; Zhang W; Xiang W; Li Z; Yang K; Duan S; Du X; Yu J; Xie Y; Wang Z; Jiang W; Zhang L; Lin X
Anal Chim Acta; 2023 Nov; 1281():341899. PubMed ID: 38783739
[TBL] [Abstract] [Full Text] [Related]
5. HIV-Associated Hypertension: Risks, Mechanisms, and Knowledge Gaps.
Prakash P; Swami Vetha BS; Chakraborty R; Wenegieme TY; Masenga SK; Muthian G; Balasubramaniam M; Wanjalla CN; Hinton AO; Kirabo A; Williams CR; Aileru A; Dash C
Circ Res; 2024 May; 134(11):e150-e175. PubMed ID: 38781298
[TBL] [Abstract] [Full Text] [Related]
6. Dosimetric Effect of Target Position Accuracy on Single-Isocenter Multiple liver Metastases SBRT.
Zhang Y; Niu S; Yuan J; Wang X; Gong C; Tang C
Technol Cancer Res Treat; 2024; 23():15330338241257422. PubMed ID: 38780512
[No Abstract] [Full Text] [Related]
7. Unveiling the role of the KLF4/Lnc18q22.2/ULBP3 axis in the tumorigenesis and immune escape of hepatocellular carcinoma under hypoxic condition.
Wei L; He P; Tan Z; Zhao L; Lin C; Wei Z
J Cell Mol Med; 2024 May; 28(10):e18411. PubMed ID: 38780505
[TBL] [Abstract] [Full Text] [Related]
8. PNPLA3 risk allele is associated with risk of hepatocellular carcinoma but not decompensation in compensated cirrhosis.
Urias E; Tedesco NR; Burkholder DA; Moran IJ; Miller MJ; Jasty VSJ; Patil S; Zoellner S; Wijarnpreecha K; Chen VL
Hepatol Commun; 2024 Jun; 8(6):. PubMed ID: 38780253
[TBL] [Abstract] [Full Text] [Related]
9. Case report: Fatal overwhelming post-splenectomy infection in a patient with metastatic angiosarcoma treated with immunotherapy.
Torrado C; Baysal MA; Chakraborty A; Norris BL; Khawaja F; Tsimberidou AM
Front Immunol; 2024; 15():1366271. PubMed ID: 38779675
[TBL] [Abstract] [Full Text] [Related]
10. ULK1 Mediated Autophagy-Promoting Effects of Rutin-Loaded Chitosan Nanoparticles Contribute to the Activation of NF-κB Signaling Besides Inhibiting EMT in Hep3B Hepatoma Cells.
Wu P; Wang X; Yin M; Zhu W; Chen Z; Zhang Y; Jiang Z; Shi L; Zhu Q
Int J Nanomedicine; 2024; 19():4465-4493. PubMed ID: 38779103
[TBL] [Abstract] [Full Text] [Related]
11. Drug screening on digital microfluidics for cancer precision medicine.
Zhai J; Liu Y; Ji W; Huang X; Wang P; Li Y; Li H; Wong AH; Zhou X; Chen P; Wang L; Yang N; Chen C; Chen H; Mak PI; Deng CX; Martins R; Yang M; Ho TY; Yi S; Yao H; Jia Y
Nat Commun; 2024 May; 15(1):4363. PubMed ID: 38778087
[TBL] [Abstract] [Full Text] [Related]
12. Development of an individualized model for predicting postoperative delirium in elderly patients with hepatocellular carcinoma.
Yan M; Lin Z; Zheng H; Lai J; Liu Y; Lin Z
Sci Rep; 2024 May; 14(1):11716. PubMed ID: 38777824
[TBL] [Abstract] [Full Text] [Related]
13. Impact of an Automated Population-Level Cirrhosis Screening Program Using Common Pathology Tests on Rates of Cirrhosis Diagnosis and Linkage to Specialist Care (CAPRISE): Protocol for a Pilot Prospective Single-Arm Intervention Study.
Flores JE; Trambas C; Jovanovic N; Thompson AJ; Howell J
JMIR Res Protoc; 2024 May; 13():e56607. PubMed ID: 38776541
[TBL] [Abstract] [Full Text] [Related]
14. Ultrasound-guided percutaneous biopsy for focal liver lesions: Adverse events and diagnostic yield in a single-centre analysis.
Pöschel T; Blank V; Schlosser T; Lingscheidt T; Böhlig A; Wiegand J; Karlas T
PLoS One; 2024; 19(5):e0304026. PubMed ID: 38776359
[TBL] [Abstract] [Full Text] [Related]
15. Evaluating the diagnostic accuracy of heat shock proteins and their combination with Alpha-Fetoprotein in the detection of hepatocellular carcinoma: a meta-analysis.
Xiang D; Fu L; Yang Y; Liu C; He Y
BMC Gastroenterol; 2024 May; 24(1):178. PubMed ID: 38773451
[TBL] [Abstract] [Full Text] [Related]
16. Effect of novel anti-tumor and anti-angiogenesis drug taurolactone on angiogenic factor AGGF1 and angiogenesis mimicry in patients with hepatocellular carcinoma.
Liu S; Wei Y; Nie L; Tang Z; Lu Q; Liang Q
BMC Cancer; 2024 May; 24(1):614. PubMed ID: 38773427
[TBL] [Abstract] [Full Text] [Related]
17. Radiotherapy and immunology.
Wang L; Lynch C; Pitroda SP; Piffkó A; Yang K; Huser AK; Liang HL; Weichselbaum RR
J Exp Med; 2024 Jul; 221(7):. PubMed ID: 38771260
[TBL] [Abstract] [Full Text] [Related]
18. The effect of liver metastases on clinical efficacy of first-line programmed death-1 inhibitor plus chemotherapy in esophageal squamous cell carcinoma: A post hoc analysis of ASTRUM-007 and meta-analysis.
Gao J; Song Y; Kou X; Tan Z; Zhang S; Sun M; Zhou J; Fan M; Zhang M; Song Y; Li S; Yuan Y; Zhuang W; Zhang J; Zhang L; Jiang H; Gu K; Ye H; Ke Y; Qi X; Wang Q; Zhu J; Huang J
Cancer Med; 2024 May; 13(10):e7203. PubMed ID: 38769930
[TBL] [Abstract] [Full Text] [Related]
19. [Role of COX-2/PGE2/EP4 Axis-induced Macrophage Functional Activation
in NSCLC Development].
Zhao J; Zhu Q; Zhang Y; Li G; Zhang Y; Li F; Bian L
Zhongguo Fei Ai Za Zhi; 2024 Apr; 27(4):245-256. PubMed ID: 38769827
[TBL] [Abstract] [Full Text] [Related]
20. Effect of cytokines on advanced hepatocellular carcinoma prognosis receiving radiotherapy and tislelizumab plus anlotinib: a single-center phase II clinical trial.
Lin YD; Wu GS; Rao MY; Liu YH; Han YW; Zhang J; Zhang JW
Sci Rep; 2024 May; 14(1):11486. PubMed ID: 38769368
[TBL] [Abstract] [Full Text] [Related]
[Next]
